Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12129263
Kinase inhibitors and uses thereof
granted -
US 12128133
Ingestible device with expandable enclosure
granted -
US 12129469
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted -
US 12128034
Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
granted -
US 12128013
Toxic aldehyde related diseases and treatment
granted -
US 12129262
CDK inhibitors and their use as pharmaceuticals
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12128014
Use of thiol compounds to treat neurological disease
granted -
US 12129471
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
granted -
US 12129476
Methods for measuring the potency of AADC viral vectors
granted -
US 12128033
Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
granted -
US 12128052
Pharmaceutical compositions comprising meloxicam
granted -
US 12129222
Production of bitter principle derivatives
granted -
US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted -
US 12128058
Multi-substituent psilocybin derivatives and methods of using
granted -
WO 2024219427
PROCÉDÉ DE PRODUCTION DE LYMPHOCYTES INNÉS DE TYPE 2
granted -
US 12121571
Recombinant L-asparaginase
granted -
US 12121522
Methods of treating cancer with an mTOR inhibitor
granted -
US 12123015
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12122998
Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
granted -
US 12121523
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 12121569
Methods and compositions for CNS delivery of iduronate-2-sulfatase
granted -
US 12121525
Methods for treating GI syndrome and graft versus host disease
granted -
US 12121288
Combination tumor treatment
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.